Hyper Corporation Inc.

A065650

KR7065650004

Computer Hardware

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
1,463 ^KRW	+1.39%		-3.18%	+48.83%

04-26	Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.	CI
04-05	Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	CI

Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding

August 23, 2022

On August 24, 2022, Medifron DBT Co., Ltd. closed the transaction.

Latest news about Hyper Corporation Inc.

Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.	04-25	CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	04-04	CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.	04-04	CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.	04-04	CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.	03-27	CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion	02-15	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding	02-14	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.	02-14	CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd	22-12-13	CI
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index	22-09-19	CI
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding	22-08-23	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding	22-08-21	CI
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	22-06-29	CI
Medifron DBT to Raise $3.9 Million via Stock Offering	22-06-22	MT
Medifron DBT to Raise $10 Million via Stock Offering	22-06-22	MT
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.	22-06-21	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors	22-06-21	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd	22-06-21	CI
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	21-09-14	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm	21-09-12	CI
Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd.	21-02-04	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 14.99999874 billion in funding from T Scientific Co., Ltd.	20-12-29	CI
Medifron DBT Co., Ltd. announced that it has received KRW 8 billion in funding	20-12-07	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 8 billion in funding	20-11-29	CI
J&Giant Spice Private Equity Partnership agreed to acquire SJ CORE CO.,LTD from Medifron DBT Co., Ltd. for KRW 22 billion.	20-11-29	CI

Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.

Sector

Computer Hardware

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Computer Hardware

	1st Jan change	Capi.
HYPER CORPORATION INC.	+48.83%	91.09M
DELL TECHNOLOGIES INC.	+91.22%	104B
HP INC.	+3.22%	30.4B
HEWLETT PACKARD ENTERPRISE COMPANY	+5.33%	23.25B
SEAGATE TECHNOLOGY HOLDINGS PLC	+15.17%	20.63B
LENOVO GROUP LIMITED	-7.51%	16.47B
LOGITECH INTERNATIONAL S.A.	+2.31%	13.88B
ASUSTEK COMPUTER INC.	+5.41%	11.92B
TD SYNNEX CORPORATION	+16.95%	10.75B
WISTRON CORPORATION	+13.59%	10B

Other Computer Hardware

Hyper Corporation Inc.

Equities

A065650

KR7065650004

Computer Hardware

Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding

Latest news about Hyper Corporation Inc.

Chart Hyper Corporation Inc.

Company Profile

Sector Other Computer Hardware